Compare AMZE & TRIB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AMZE | TRIB |
|---|---|---|
| Founded | 2019 | 1992 |
| Country | United States | Ireland |
| Employees | 4 | N/A |
| Industry | Beverages (Production/Distribution) | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
| Sector | Consumer Staples | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 14.3M | 14.0M |
| IPO Year | N/A | 1996 |
| Metric | AMZE | TRIB |
|---|---|---|
| Price | $0.28 | $0.78 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $3.00 | N/A |
| AVG Volume (30 Days) | ★ 762.8K | 182.5K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $6,741.66 | $13.51 |
| Revenue Next Year | $100.61 | $13.14 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.24 | $0.48 |
| 52 Week High | $11.76 | $3.44 |
| Indicator | AMZE | TRIB |
|---|---|---|
| Relative Strength Index (RSI) | 35.29 | 51.88 |
| Support Level | $0.24 | $0.65 |
| Resistance Level | $0.41 | $0.79 |
| Average True Range (ATR) | 0.03 | 0.06 |
| MACD | -0.00 | 0.01 |
| Stochastic Oscillator | 12.67 | 66.83 |
Amaze Holdings Inc is a software company dedicated to empowering creators by providing comprehensive software solutions and services that facilitate e-commerce, social commerce, integrated commerce selling experiences, and the distribution of a premium wine brand. The group offers an end-to-end, creator-powered commerce platform offering tools for seamless product creation, modern e-commerce solutions, and scalable managed services.
Trinity Biotech PLC is in the business of developing, manufacturing, and marketing clinical diagnostic products for clinical laboratory and point-of-care sections of the diagnostic market. Its products are used to detect autoimmune, infectious, sexually transmitted diseases, diabetes, and disorders of the liver and intestine. The company also provides raw materials to the life sciences and research industries globally. It markets products under the brand names Recombigen, Unigold, MarBlot, Mardx, Immublot, and others. Geographically, it has two segments namely the Americas, and the Rest of World - Ireland from which it derives a majority of its revenue from the Americas segment.